Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Comparative Effects of Aerobic Exercises and Jacobson's Progressive Relaxation Technique in Primary Dysmenorrhea

1. juni 2026 oppdatert av: Riphah International University

Comparative Effects of Aerobic Exercises and Jacobson's Progressive Relaxation Technique on Pain, Fatigue and Quality of Life in Primary Dysmenorrhea

The study will focus on the comparative effects of aerobic exercises and Jacobson's progressive relaxation technique on pain, fatigue and quality of life in primary dysmenorrhea.

This study will be a randomized clinical trial and will be conducted in, Superior college depalpur and Army public schools and college Lahore (APSACS). Non probability convenience sampling will be used to collect the data.64 participants will be selected on the basis of inclusion and exclusion criteria and will be equally divided into two groups by sealed opaque enveloped .Participants having age group between 17-24 years and diagnosed with WaLiDD score are included.

Studieoversikt

Status

Rekruttering

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

Primary dysmenorrhea (PD) refers to menstrual pain without organic lesions in the pelvic cavity , which mainly manifests as spastic pain and distension above the symphysis pubis in the lower abdomen before and after or during menstruation, radiating to the lumbosacral region and inner thigh. PD is a common gynecological disorder affecting 50%-90% of women. The study will focus on the comparative effects of aerobic exercises and Jacobson's progressive relaxation technique on pain, fatigue and quality of life in primary dysmenorrhea.

This study will be a randomized clinical trial and will be conducted in, Superior college depalpur and Army public schools and college Lahore (APSACS). Non probability convenience sampling will be used to collect the data.64 participants will be selected on the basis of inclusion and exclusion criteria and will be equally divided into two groups by sealed opaque enveloped .Participants having age group between 17-24 years and diagnosed with WaLiDD score are included. Athletes and married women will be excluded. Outcome measures will be taken using Numeric pain rating scale (NPRS) for pain, EQ-5D-5L questionnaire for quality of life, fatigue assessment scale for fatigue. Both Groups will receive same baseline treatment which is core muscle strength. Group A will receive aerobic exercises and Group B will receive Jacobson's progressive relaxation technique for 3 times in a week. The treatment will be given for 8 weeks. Outcome measures will be measured at baseline and after 8 weeks. Data analysis will be done by SPSS version 25.

Studietype

Intervensjonell

Registrering (Antatt)

58

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

  • Pakistan
    • Punjab Province
      • Okāra, Punjab Province, Pakistan, 52513
        • Rekruttering
        • Superior college for women and Polytechnic institute
        • Hovedetterforsker:
          • Aansa Manzoor, MSWHPT

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Barn
  • Voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Pain on numeric rating pain scale,
  • Menarche range 12-16,
  • BMI less than 30,
  • Having a regular menstrual cycle (28-32) days,
  • Normal bleeding days (3 to 1) and diagnosed with mild PD according to WaLiDD score

Exclusion Criteria:

  • Athletes,
  • married women with gynaecological abnormalities were excluded,
  • Medical treatment during the study (e.g., oral contraceptives, antidepressants)
  • Recent musculoskeletal trauma or surgery, or chronic musculoskeletal disorders
  • affecting pain perception (e.g., fibromyalgia, pelvic floor dysfunction)
  • secondary dysmenorrhea-related conditions (e.g., endometriosis, fibroids, ovarian cysts),
  • consumption of painkillers
  • No mental or physical diseases, which reduce the abilities to exercise

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: aerobic exercises
Group A will receive aerobic exercises for 3 times in a week.
Annen: aerobic exercises

Group A Duration of forty five minutes Warm up exercises for 10 minutes. Free active movement of upper limb, lower limb, and upper body, cross toe to touch dynamic stretches such as lunges, Achilles tendon and hamstrings stretching. The aerobic workout duration will be 25mins.. The aerobic exercise involved the following steps with15reps of each exercise and while changing the step slow marching step for 15second and then move towards the next step.

single step touch, double step touch, step touch front and back ,grapevine, knee lift , lunge side and back, L step ,V step, jumping jacks. Cool down exercises for 10 minutes included slow marching, quadriceps and hamstring and stretching. Subjects were prohibited from aerobics during menstruation and data were recorded for two menstrual cycles.
Eksperimentell: Jacobson's progressive relaxation technique
Group B will receive Jacobson's progressive relaxation technique for 3 times in a week.
Annen: Jacobson's relaxation technique
Group B Jacobson's relaxation technique is a type of therapy that focuses on tightening and relaxing specific muscle groups in a sequence that makes you feel calmer and makes you aware of your body and physical sensations. It is also known as PMRT. (39) JPRT was applied three times a week from the estimated date of ovulation to the onset of the next menstruation. . The participants were in a supine position and were supported with cushions. The JPRT involves participants actively contracting muscles to create tension and then progressively releasing them. First of all, the participants were asked to contract the muscles tightly and hold for slow count of 5seconds (s) and then relax them completely for 10 s. At the same time, the participants practiced diaphragmatic breathing. The participants repeatedly performed JPMRT for each body part. Each session lasted about 20-30 min.
Andre navn:
  • Aerobic exercises and hypopressive

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
WaLlDD relaxation technique on pain, fatigue and quality of life in primary dysmenorrhea.
Tidsramme: 2 months
At baseline, the participant scored at the initial level on the WaLliDD scale, indicating their starting status. Over time, changes in the score reflect improvement or decline in the measured outcome. An increase in score suggests positive progress in the targeted domain, while a decrease indicates reduced functioning or worsening condition compared to baseline.
2 months
Fatigue Assessment Scale
Tidsramme: 2 months
At baseline, the participant's fatigue level is measured using the Fatigue Assessment Scale, providing a starting score of perceived fatigue. Changes in the score over time indicate variation in fatigue severity. A decrease from baseline reflects improvement (reduced fatigue), while an increase indicates worsening fatigue compared to the initial assessment.
2 months
EQ-5D-5-L-Questionnaire
Tidsramme: 2 months
The EQ-5D-5L is a standardized questionnaire used to assess health-related quality of life. It measures five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each rated on five levels of severity. It also includes a visual analog scale (VAS) where individuals rate their overall health. Higher scores indicate better perceived health status.
2 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Riphah International University

Etterforskere

  • Hovedetterforsker: Hafiza Iqra Rubab, MSWHPT, Riphah International University

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. oktober 2025

Primær fullføring (Antatt)

1. juli 2026

Studiet fullført (Antatt)

1. juli 2026

Datoer for studieregistrering

Først innsendt

1. juni 2026

Først innsendt som oppfylte QC-kriteriene

1. juni 2026

Først lagt ut (Faktiske)

5. juni 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

5. juni 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

1. juni 2026

Sist bekreftet

1. juni 2026

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • REC/RCR&AHS/25/0514

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere